GH1 and Turner syndrome: Although observed NFH-SDS was similar, these findings highlight how differences in pubertal timing and treatment duration may influence growth outcomes in routine clinical practice and should be interpreted as reflecting real-world growth trajectories rather than intrinsic biological responsiveness to GH therapy.<h4>What is known</h4>• Growth hormone therapy is an established treatment for short stature in both SHOX deficiency and Turner syndrome.